Follow-up of breast cancer patients. State of the art;LA SURVEILLANCE D'UNE FEMME TRAITEE POUR CANCER DU SEIN

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 27, Issue 1, 1998, Pages 21-33

  Lansac, J ^a   Diouf, A ^a  

^a CHU BRETONNEAU   (France)

Author keywords

Breast; Cancer; Follow up

Indexed keywords

BREAST CANCER; BREAST EXAMINATION; BREAST RECONSTRUCTION; CARCINOMA IN SITU; CLINICAL EXAMINATION; CONTRACEPTION; COST BENEFIT ANALYSIS; FEMALE; FOLLOW UP; GYNECOLOGICAL EXAMINATION; HEALTH CARE COST; HUMAN; MAMMOGRAPHY; MENOPAUSE; METASTASIS; PRACTICE GUIDELINE; PSYCHOLOGICAL ASPECT; RECURRENCE RISK; RECURRENT CANCER; RELAPSE; REVIEW; SOCIAL ASPECT; SURVIVAL RATE;

AFTERCARE; BREAST NEOPLASMS; BREAST SELF-EXAMINATION; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; NEOPLASM RECURRENCE, LOCAL; PHYSICAL EXAMINATION; SURVIVAL ANALYSIS;

EID: 0031976514     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (74)

1. Haagensen CD, Lane N, Lattes R. Lobular neoplasia (so called lobular carcinoma in situ) of the breast. Cancer 1978;42:737-69.
2. Rosen P. Lobular carcinoma in situ: recent clinico pathologic studies at memorial hospital. Pathol Res Pract 1980;166:430-55.
3. Rouesse J, Contesso G. Le cancer du sein. Paris, Hermann,1985.
4. Chauvergne J, Avril A, Durand M. Indications et résultats thérapeutiques. In: Cancers gynecologiques et mammaires. Paris, Flammarion, 1986:380-98.
5. Pellier D, Chavanne G. La surveillance par mammographie des cancers du sein irradiés. J Radiol 1975;56:324-7.
6. Roseman J, Bernard S, Kober C. Local recurrences in patients with breast cancer at the north. Carolina memorial hospital. Cancer 1986;57:1421-5.
7. Host H, Brennhoud LO. The effect of post operative radiotherapy in breast cancer, Int J Radiot Oncol Biol Phys 1977;2:1061-7.
8. Wallgren A. A controlled study: pre operative vesus post operative breast cancer. Cancer 1979;43:956-60.
9. Lewitt SH, Mc Hugh RB, Song LW. Radiotherapy in the post operative treatment of operable cancer of the breast evaluation of the effectif radiation. Cancer 1973;31:933-40.
10. Schapira D, Urban N. A minimalist policy for breast cancer surveillance. JAMA 1991;16:380-2.
11. Harris JR, Recht A, Almaric R. Time course and prognosis of local recurrence following primary radiation therapy for early breast cancer. J Clin Oncol 1984;2(1):37-41.
12. Marret H, Meunier N. Récidives locales après traitement concervateur des cancers du sein. Tours, Thèse Médecine, 1995.
13. Pierquin B, Raynal M, Otmezguine Y. Le traitement conservateur des cancers du sein. In: Le traitement conservateur du cancer du sein. Paris, Cedem, 1988;67-71.
14. Vicoq JR, Fourquet A, Campana F. Cancer du sein le traitement conservateur à l'Institut Curie. In: le traitement conservateur du cancer du sein. Paris, 1988;149-58.
15. Recht A, Sadowsky N, Cady B. Clinical problems in follow up of patients after conservative surgery and radiotherapy. Surgical Clinics of North America 1990;70:1179-86.
16. Fowble BL, Solin LJ, Schultz DJ. Ten year results of conservative surgery and irradiation for stage one and II breast cancer, Int J Radiat Oncol Biol Phys 1991;21:269-77.
17. Kurtz JM, Jacquemier J, Almaric R. Risk factors for reccurence in premenopausal and post menopausal patients with ductal cancers treated by conservation therapy. Cancer 1990;65:1867-78.
18. Kurtz JM, Spitalier JM, Almaric R. The prognostic significance of late local recurrence after breast concerving therapy. Int J Radiat Oncol Biol Phys 1990;18:87-93.
19. Lemseffer A. Récidives locales après traitement conservateur des cancers du sein. Tours, Thèse de Médecine, 1990.
20. Dewar J, Kerr G. Value of routin follow up of women treated for early carcinoma of the breast. Br Med J 1985;291:1464-7.
21. Haagensen CD. Disease of the breast. Philadelphia, Saunders, 1971;449-58.
22. Fracchia AA, Borgen PI. Bilateral breast cancer. Semin Surg Oncol 1991;7:300-5.
23. Lee CG, MC Cormick B, Mazumdar M. Infiltrating breast carcinoma in patients age 30 years and younger: long term outcome for life, relapse, and second primary tumor. Int J Radiat Oncol Biol Phys 1992;23:969-75.
24. Nielsen M, Christensen L, Andersen J. Controlateral cancerous breast. Lesions in women with clinical invasive breast carcinoma. Cancer 1986;57:897-903.
25. Kemeny F, Kemeny JL, Amouroux J. Diffusion du processus carcinomateux: sein homocontro-latéral métastases, ganglions. Evaluation des moyens de diagnostic du cancer du sein. Paris, JMT, 1981;215-25.
26. Clark C, SLEdge G, Osbome C. Survival from first recurrence : relative importance of prognostic factors in 1015 breast cancer patients. J Clin Oncol 1987;5(1):55-61.
27. Winchester D, Sener S, Kandekar J. Symptomatology as an indicator of recurrent or metastatic breast cancer. Cancer 1979;43:956-60.
28. Pandya K, Mc Fadden, Kalish L. Fregnency and patterns of early recurrences and method of detection in operable breast cancer with pathologically positions axillary lymph nodes. On eastern cooperation oncology group adjuvant studies a preliminary report. Cancer 1983;2:117-22.,
29. Zwaveling A, Albers G, Felthuis W. An evaluation of routine follow up for detection of breast cancer recurrence. J Surg Oncol 1987;34:194-7.
30. Broyn T, Froyen J. Evaluation of routine follow up after surgery for breast carcinoma. Acta Chir Scand 1982;148:401-4.
31. Tate J, Clifford PC, Royle G, Buchanan R. After surgery for breast cancer: wich mode of surveillance ? J Royal Soc Med 1989;82:737-8.
32. Hughest L, Courtney S. Follow up of patients with breast cancer. Br Med J 1985;290:1229-30.
33. Solin L, Fowble B, Troupin R. Biopsy results of new calcifications in the post irradiated breast. Cancer 1989;63:1956-61.
34. Stomper PC, Recht A, Berenberg A. Mammographic dectection of recurrent cancer in the irradiated breast. Am J Radiol 1987;148:39-43.
35. Balu-Maestro C, Bruneton JN, GeoffraY A. La surveillance échographique du cancer du sein traité. J Radiol 1991;72:655-61.
36. Dilhuidy MH, Barreau B, Dilhydy JM. Place de l'échographie mammaire dans l'étude des seins traumatiques opérés et irradiés. J Le Sein 1994;4:130-41.
37. Heywang SH, Wolf A, Pruss E. MR imaging of the breast with Gd-DTPA: use and limitations. Radiology 1989;171:95-103.
38. Kerslake RW, fox JN, Carleton PJ. Dynamic contraced enhanced and fat suppressed magnetic resonance imaging in suspected recurrent carcinoma of the brest: preliminary experience. Br J Radiol 1994;67:1158-68.
39. Libshitz HI, Montague E, Paulus D. Calcifications and the therapeutically irradiated breast. AJR 1977;128:1021-5.
40. Tristant H, Baillet AM. L'examen mammographique avant et après traitement conservateur: du cancer du sein. In le traitement conservateur du cancer du sein. Paris, Cedem, 1988;25-42.
41. Senofstky G, Wanebo H, Wilhelm M. Has monitoring of the contro lateral breast improved the prognosis in patients treated for primary breast cancer. Cancer 1986;57: 597-602.
42. Leis P. Managing the remaining breast. Cancer 1980;46:1026-30.
43. e Journées d'Oncologie Gynécologique, mars 1988;27-28.
44. Givio investigators. Impact of follow up testing on survival and health related quality of life in brest cancer patients. A multi center randomized control trial. JAMA 1994;271:1587-1592.
45. Del Turco MR, Palli D, Carridi A. Intensive diagnostic follow up after treatment of primary breast cancer: a randomized trial. JAMA 1994;271:1593-7.
46. Chaudary MA, Maisey MN, Shaw PJ. Sequential bone scans and chest radiographs in the post operative management of early breast cancer. Br J Surg 1983;70:517-8.
47. Pedrazzini A, Gelber R, Isley M. First repeated bone scan in the observations of patients with operable brest cancer. J Clin Oncol 1986;4:389-94.
48. Logager VB, Vestergaarda, Herrsedt J. The limited value of the follow up in patients operated for brest carcinoma. Europ. J Cancer 1990;26:553-5.
49. Nicoli Acarpi A, DI Marcog. A rational post operative follow up with carcinœmbryonic antigen, tissue polypeptide antigen and urinary hydroxyprolin in breast cancer patients. Cancer 1989;63:2037-46.
50. Namer M, Ramaioli A, Fontana X. Les marqueurs tumoraux sériques des cancers du sein. Cahiers Cancer 1990;2:565-74.
51. Rutqvist LE, Johansson H, Signomklao T. Adjuvant tamoxifen therapy for early stage brest cancer and second pimary malignancie. Stockholm Breast cancer study group. J Natl Cancer Inst 1995;87:645-51.
52. Ciatto S, Cecchini S, Bonardi R. Ultra sonography surveillance of the endometrium in brest cancer patients on adjuvant tamoxifen. Lancet 1994;344:60.
53. Cohen I, Altaras MM, Beyth Y. Ultrasonographic evaluation of the endometrium in post menopausal tamoxifen treated patients. Am J Obstet Gynecol 1995;172:1067-8.
54. Feig S. The role of new imaging modalities in staying and follow up of breast cancer. Seminars in Oncology 1986;13:402-14.
55. Feig S. Imaging techniques and guidelines for evaluation and follow up of breast cancer patients. CRC criticial review in diagnostic imaging 1987;27:1-16.
56. e Assises françaises de Gynécologie. Masson 1985;315-25.
57. Zysman H. Des hommes, des cancers et des autres. Symposium sur la réinsertion des cancéreux guéris. Besançon, 1980.
58. e Journées d'Oncologie Gynécologique, mars 1988;48-54.
59. Schraub S. Epidemiologie, coût moral et financier des traitements adjuvants des cancers du sein. In: D Serin. Cancer du sein définition du haut risque métastatique. Paris, Masson, 1987;69-74.
60. Orminston M, Timoney A, Oureschi A. Is follow up of patients after surgery for breast cancer worth while. J Roy Soc Med 1985;78:920-921.
61. Tomin R. Screening for recurrent breast cancer. Its effectiveness and pronostic value. J Clin Oncol 1987;5:62-7.
62. Ojeda M, Alonso M, Bastus R. Follow up of breast cancer stage I et II. An analysis of some common methods. Eur J Cancer Oncol 1987;23:419-23.
63. Horton J. Follow up of breast cancer patients. Cancer 1984;53:790-7.
64. e Journées d'Oncologie Gynécologique. Marseille, mars 1988;55-64.
65. Rutgers E, Van Slooten E, Kluck H. Follow up after treatment of primary breast cancer. Br J Surg 1989;76:187-9.
66. Tabar L, Fagerberg G, Duffy SW, Day N. The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit. J Epidemiol Community Heath 1989;43:107-4.
67. Sankila R, Heinavaraa S, Hakulinen T. Survival of brest cancer patients after subsequent term pregnancy: «healthy mother effect ». Am J Obstet Gynecol 1994;170:818-23.
68. Love R. Hormone treatment in women with excellent breast cancer. Oncology 1990;4:59-60.
69. Spicer D, Pike M, Henderson B. The question of estrogen replacement therapy in patients with a prior diagnosis of breast cancer. Oncology 1990;4:49-59.
70. Seoud M, Johnson J, Weed J. Gynecologic tumors in Tamoxifen treated women with breast cancer. Obstet Gynecol 1993;82:165-9.
71. Sitruk-Ware R, Utian WH. The menopause and hormonal replacement therapy. Facts and contreversies. Dekker, 1991.
72. Wren BG. Hormone therapy following breast and uterine cancer. Baillière's Clinical Endocrinology and Metabolism 1993;7:225-42.
73. Disaia P. Hormone replacement therapy in patients with breast cancer: a reappraisal. Cancer 1993;71:1490-500.
74. Hutchinson-Williams K, Gutman JN. Estrogen replacement therapy in high risk cancer patients. Yale J Biol Med 1991;64:607-26.